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Sexual (dys)function and the quality of sexual life in
patients with colorectal cancer: a systematic review
M. J. Traa1, J. De Vries1,2, J. A. Roukema1,3 & B. L. Den Oudsten1,4*
1Department of Medical Psychology, CoRPS—Center of Research on Psychology in Somatic Diseases, Tilburg University, Tilburg, The Netherlands; Departments of
2Medical Psychology; 3Surgery; 4Education and Research, St Elisabeth Hospital, Tilburg, The Netherlands
Received 18 October 2010; revised 26 January 2011; accepted 21 February 2011
Background: To determine (i) the prevalence of sexual (dys)function in patients with colorectal cancer and (ii)
treatment-related and sociodemographic aspects in relation to sexual (dys)function and the quality of sexual life.
Recommendations for future studies are provided.
Methods: A systematic search was conducted during the period 1990 to July 2010 that used the databases PubMed,
PsychINFO, The Cochrane Library, EMBASE, and OVID Medline.
Results: Eighty-two studies were included. The mean quality score was 7.2. The percentage of preoperatively potent
men that experienced sexual dysfunction postoperatively varied from 5% to 88%. Approximately half of the women
reported sexual dysfunction. Preoperative radiotherapy, a stoma, complications during or after surgery, and a higher
age predicted more sexual dysfunction with a strong level of evidence. Type of surgery and a lower tumor location
predicted more sexual dysfunction with a moderate level of evidence. Insufficient evidence existed for predictors of the
quality of sexual life. Current studies mainly focus on biological aspects of sexual (dys)function. Furthermore, existing
studies suffer from methodological shortcomings such as a cross-sectional design, a small sample size, and the use of
nonstandardized measurements.
Conclusion: Sexuality should be investigated prospectively from a biopsychosocial model, hereby including the
quality of sexual life.
Key words: colorectal cancer, quality of sexual life, sexual dysfunction, sexual functioning, sexuality, systematic
review
introduction
Worldwide, colorectal cancer is the third most common cancer
in men (10%), after lung cancer (17%) and prostate cancer
(14%), and the second most common cancer in women (9%)
after breast cancer (22%) (www.globocan.iarc.fr).
Despite improvements in the multimodality treatment of
colorectal cancer, surgery remains the only treatment offering a
chance of cure. For colon cancer, surgery is aimed at total
resection of the tumor with adequate margins and
lymphadenectomy (i.e. colectomy) [1]. In general, the
remaining parts of the colon are anastomosed together to create
a functioning colon; however, sometimes a temporary
colostomy may be constructed [2]. For rectal cancer, different
surgical approaches are warranted. An anterior resection (AR),
with preservation of the sphincter function, is carried out for
tumors located in the middle or upper part of the rectum. For
very low tumors, an abdominal perineal resection (APR) is
carried out, hereby resecting the anal sphincter and forming a
permanent colostomy [1]. In general, surgery that includes total
mesorectal excision (TME) offers the best results [3]. Colon
cancer can be safely treated by open or laparoscopic surgery [4];
however, laparoscopic rectal cancer surgery is in the
experimental phase [5]. Preoperative radiation therapy (PRT)
or preoperative chemoradiation therapy (PCRT) leads to an
additional reduction of local recurrence rates [6, 7].
Although oncologic cure and overall survival are the main
goals of treatment, functional results such as fecal incontinence,
urinary functioning, and sexual functioning are also important.
Furthermore, patient-centered outcomes, such as quality of life,
are regarded as key measurements in assessing outcomes of
interventions [8]. Quality of life is a multidimensional
construct, incorporating at least physical, psychological, and
social well-being [9]. Sexuality and intimacy are considered
central to a person’s well-being and are, as such, important
aspects of quality of life [10]. Poor sexual functioning and a
lower sexual satisfaction are risk factors for a worse quality of
life [11]. Sexual functioning refers to the normal performance
standards of the sexual response cycle [12], which consists of
four phases: desire, excitement, orgasm, and resolution [13]. A
sexual dysfunction is characterized by a disturbance in this
sexual response cycle or by pain associated with intercourse
[14]. In line with the distinction between health status (i.e. the
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subjective evaluation of this functioning) [15–17], a similar
distinction can be made between sexual (dys)function and the
quality of sexual life. Sexual (dys)function refers mainly to the
biological aspects of sexuality (e.g. ‘When you had sexual
stimulation or intercourse, how often did you reach orgasm?’),
while the quality of sexual life takes into account the person’s
subjective evaluation of his/her sexual functioning (e.g. ‘How
satisfied were you with your ability to reach orgasm during
sexual activity or intercourse?’).
Several authors have emphasized the assessment of sexual
(dys)function from a biopsychosocial perspective [12, 18].
Hereby, are not only treatment-related aspects important (e.g.
the type of surgery and (neo)adjuvant treatments) but also
psychosocial factors (e.g. mood, the partner relationship, and
the subjective evaluation of the current functioning). These
factors may have a direct or indirect effect on sexual
(dys)function or the quality of sexual life. For instance, sexual
function can not only be directly affected by surgical treatment
[19] or by PRT or PCRT [20–22] but can also be indirectly
affected due to the potential loss of sphincter function,
accompanied with a stoma [20, 23].
Published research focused on several aspects associated with
sexual dysfunction in patients with colorectal cancer. To our
knowledge, an overview of these studies has not yet been
published. Knowledge of how colorectal cancer and its
treatment affect patients will give health professionals
opportunities to adequately support this patient group. The
objective of this qualitative systematic review was to provide an
overview of studies that addressed sexual (dys)function and/or
the quality of sexual life in colorectal cancer with regard to (i)
the prevalence of sexual (dys)function and (ii) treatment-
related and sociodemographic aspects in relation to sexual
(dys)function and/or the quality of sexual life.
methods
search strategy
A search of the literature was carried out in PubMed (196 hits), Ovid
Medline (328 hits), PsychINFO (7 hits), The Cochrane Library (67 hits), and
EMBASE (534 hits). The databases were searched with combinations of
colorectal cancer* (colon cancer*, colonic cancer*, rectal cancer*, colorectal
cancer*, rectum cancer*, colon tumo*, colonic tumo*, rectal tumo*,
colorectal tumo*, rectum tumo*, colon neoplas*, colonic neoplas*, rectal
neoplas*, colorectal neoplas*, rectum neoplas*) and combinations of sexual
funct* (sexual behav*, sex behav*, sexual funct*, sex funct*, ‘sexual and
gender disorders’, sexual disorder*, sex disorder*, sexual dysfunct*, sex
dysfunct*, dyspareun*, erect*, coit*, ‘quality of sexual life’, ‘sexual quality of
life’). The search was restricted to studies published from 1990 to July 2010
in English or Dutch journals. Only original reports were included.
Subsequently, the reference lists of included studies were checked in order to
identify studies that were not found in the computerized database searches.
selection criteria
Studies that met the following criteria were included: (i) the studies
investigated sexual (dys)function and/or the quality of sexual life as a
primary or secondary objective; (ii) the study population exclusively
concerned patients with colon and/or rectal cancer; (iii) sexual
(dys)function and/or the quality of sexual life were measured by self-report
or an interview; (iv) the studies were original full reports published in
English or Dutch; (v) studies were published in peer-reviewed journals; (vi)
studies reported on patient populations recruited after 1989 since in the
past two decades substantial improvements in surgical techniques have
taken place, such as the introduction of TME [24].
data extraction
Combining the search results and removing duplicates resulted in 698 hits.
Two authors (MJT and BLDO) applied the described inclusion criteria
independently in a standardized manner. Disagreements between the two
reviewers (<5%) were resolved in a consensus meeting. Altogether, 590
articles were excluded based on title and abstract. Hard copies were
obtained of 108 studies, of which 81 met the selection criteria. With regard
to multiple reports on the same study, only one article was included based
on the highest quality score. If studies were of equal quality, only the
most recent study was included. Six articles were excluded based on this
criterion. Through a hand search, seven additional articles were found that
met the selection criteria. Thus, a total of 82 articles remained. The
flow chart of study selection is shown in Figure 1.
quality assessment
The methodological quality of the selected studies was independently
assessed by two reviewers (MJT and BLDO) using a criteria list (Table 1).
This checklist was based on established criteria lists for systematic reviews
that have been previously published [25, 26]. The maximum attainable
score is 15. If a criterion is not sufficiently fulfilled or not explicitly
mentioned, a 0 is scored. Studies scoring ‡70% of the maximum attainable
score (i.e. ‡11 points) were considered to be of a ‘high quality’. Studies of a
‘moderate quality’ scored between 50% and 70%, while studies scoring
<50% (i.e. £7 points) were considered as ‘low quality’.
levels of evidence
After the individual quality of the studies was assessed, the level of evidence
was determined for predictors of sexual dysfunction and the quality of
sexual life. Findings were considered consistent if ‡75% of the studies that
investigated a particular predictor showed the same direction of association.
Table 2 provides an overview of the four levels of evidence.
data synthesis
The included studies investigated diverse outcomes (i.e. different phases
and aspects of the sexual response cycle) in various patient populations,
using different study designs. Therefore, a quantitative approach (i.e. a
meta-analysis) was not possible. The information extracted from the
individual reports is summarized in the supplemental Table S1 (available at
Annals of Oncology online). As said, various biopsychosocial factors may
have an effect on sexual (dys)function and the quality of sexual life.
Unfortunately, most of the current studies focus on treatment-related or
sociodemographic aspects of sexual dysfunction, hereby neglecting
psychosocial factors that may influence sexual (dys)function and/or the
quality of sexual life. In addition, in the current studies, it is difficult to
identify the contribution of each aspect in the development of sexual
dysfunction or changes in the quality of sexual life.
In this review, the prevalence of sexual dysfunction is described for
both men and women. Subsequently, treatment-related predictors and
sociodemographic predictors of sexual dysfunction and the quality of sexual
life are discussed. The main results of the prospective and cross-sectional
studies are presented, which are specified for men and women when applicable.
results
methodological quality
There was <5% disagreement between the two reviewers when
scoring the articles. These disagreements were mainly due to
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differences in applying criterion I. The disagreements were
solved through discussion in a consensus meeting. The quality
scores ranged from 3 (low quality) [27–30] to 12 (high quality)
[20, 31]. The mean quality score was 7.2 (3–12; standard
deviation = 2.2). Methodological shortcomings mainly
concerned the following items: describing potential prognostic
factors by using multivariate analyses or structural equation
modeling (criterion G; 81%); participation rates for patient
groups are described and these rates are exceeding 75%
(criterion H; 73%); information is given about the ratio
nonresponders versus responders (criterion I; 95%); the design
is longitudinal (criterion L; 82%); and the loss to follow-up is
described and is <20% (criterion N; 90%).
study characteristics
Sample sizes ranged from 4 [32] to 1437 [33]. In total, 39
(48%) studies investigated sexual (dys)function as a secondary
objective (as part of clinical outcome studies or as part of
studies on health-related quality of life/health status) [23, 29,
33–69]. The majority of studies were cross-sectional, except for
36 (44%) studies [5, 20, 21, 23, 27, 30, 31, 35, 37, 38, 41, 44,
46, 48, 50, 54, 57, 60, 61, 66, 67, 70–80]. Of the prospective
studies, seven studies failed to define the exact postoperative
measurement point [48, 71, 73, 76, 79, 81, 82]. Six studies
investigated the results of a randomized trial [20, 35, 37, 44, 46,
66]. The study duration ranged from 3 months [30, 54] up to
5 years [21]. Four studies used a healthy population as a control
group [32, 42, 63, 73]; one study investigated both patients and
their caregivers [64]. Postoperative sexual (dys)function in men
was investigated in 28 (34%) studies [5, 22, 27, 29, 30, 35, 45,
54, 62, 67, 70–72, 74–76, 79, 80, 83–92], 7 (9%) studies
investigated women [21, 28, 32, 93–96], and 47 (57%) studies
investigated both men and women [20, 23, 31, 33, 34, 36,
38–44, 46, 48–53, 55–61, 63–66, 68, 69, 73, 77, 78, 81, 82,
97–102]. The results were mainly presented for sexually active
patients; however, not all patients were sexually active or willing
to answer questions concerning sexual (dys)function and/or the
quality of sexual life.
Six different standardized self-report instruments were
applied. The colorectal cancer-specific European Organization
for Research and Treatment of Cancer Quality of Life
Questionnaire (EORTC QLQ-CR38) [104] was most used in 23
(28%) studies [23, 33–36, 39–43, 47, 48, 50–52, 57, 58, 63–66,
99]. Regarding sexual (dys)function and the quality of sexual
life, the EORTC QLQ-CR38 measures sexual functioning,
sexual enjoyment, and sexual dysfunction in men and women
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Function (IIEF) [105] was most assessed in 13 (16%) studies [5,
22, 45, 66, 68, 70, 73, 74, 76, 87, 98–100]. The IIEF is a 15-item
questionnaire that evaluates men’s sexual functioning,
including erectile function, orgasmic function, sexual desire,
intercourse satisfaction, and overall satisfaction. The most used
female counterpart was the Female Sexual Function Index
(FSFI) [106], which was used in 3 (4%) studies [66, 68, 95, 99].
The FSFI is a 19-item questionnaire addressing six domains of
women’s sexual function: arousal, lubrication, orgasmic
function, sexual desire, intercourse satisfaction, and sexual
pain.
Several studies used a combination of instruments; however,
43 (52%) studies used nonstandardized assessments [20, 21,
27–31, 37, 38, 44, 46, 49, 53–56, 60–62, 67, 69, 72, 75, 77–83,
85, 86, 88–94, 96, 97, 101–103]. One study investigated sexual
(dys)function based on a single question: ‘Did your health
status and/or treatment cause your sexual life to decline?’ [46].
Most studies described at least 2 demographic and clinical
variables of interest. The most reported demographic variables
were age and sex; frequently represented clinical variables
were type of surgery, tumor–node–metastasis stage, distance of
the tumor from the anal verge, and (neo)adjuvant therapies.
Patients with rectal cancer were investigated in 66 (81%)
studies [5, 20–22, 27, 29–31, 34–54, 57–62, 70, 71, 73–81, 83,
85, 87–89, 91, 93, 96, 97, 98–100, 102, 103], 2 (2%) studies
concerned patients with colon cancer [68, 69], and 14 (17%)
studies investigated patients with colon or rectal cancer [23,
28, 33, 63–67, 82, 84, 86, 92, 94, 95]. Therefore, results
presented will concern patients with rectal cancer unless
explicitly mentioned.
the prevalence of sexual (dys)function in patients
with colorectal cancer
Preoperatively, the percentage of sexually active men varied
from 37% [78] to 79% [20] across studies. The percentage of
preoperatively potent men that experienced sexual dysfunction
postoperatively varied from 5% [98] to 88% [88]. Compared
with preoperative scores, a postoperative increase in erectile
dysfunction [5, 20, 27, 30, 71, 72, 78, 80, 82, 98] and/or
ejaculatory dysfunction [20, 22, 30, 54, 78, 80] was most
reported. In addition, sexual desire decreased postoperative [5,
22, 76].
The percentage of preoperatively sexually active women
ranged from 27% [78] to 78% [68]. Women who were sexually
active preoperatively remained sexually active postoperative
[77, 96]. Women reported sexual dysfunction such as
dyspareunia [20, 21, 82] and vaginal dryness [20, 99]. Twelve
months after treatment, sexual desire remained unchanged in
women [77].
For both men and women, the prevalences of sexual
(dys)function found in cross-sectional studies did not deviate
significantly from the results of the above-mentioned
prospective studies.
treatment-related aspects in relation to sexual
(dys)function
(P)RT predicted sexual dysfunction with a strong level of
evidence [20–22, 75, 99]. Radiation therapy (RT) predicted less
sexual activity in both men and women [75, 99] and erectile
Table 1. List of criteria for assessing the methodological quality of studies on sexual (dys)function and/or the quality of sexual life in patients with
colorectal cancer
Positive if
Sexual (dys)function and/or the quality of sexual life assessment
A. A psychometrically sound questionnaire is used
B. Examining sexual (dys)function and/or the quality of sexual life was a primary objective of the study
Study population concerning sexual (dys)function and/or the quality of sexual life
C. Examining both men and women
D. A description is included of at least two sociodemographic variables (e.g. age, sex, employment status, educational status, etc.)
E. A description is present of at least two clinical variables (e.g. TNM or Dukes classification, type of surgery, tumor location, etc.)
F. Inclusion and/or exclusion criteria are provided
G. The study describes potential prognostic factors by using multivariate analyses or structural equation modeling
H. Participation rates for patient groups are described (defined as the percentage of eligible patients who gave their informed consent) and these rates
are >75%
I. The ratio nonresponders versus responders is given (defined as the ratio of patients who withdrew their initial informed consent), including
reasons for withdrawal
Study design concerning sexual (dys)function and/or the quality of sexual life
J. The study sample includes at least 75 patients (arbitrarily chosen).
K. The collection of data is prospectively gathered with at least two assessment points
L. The design is longitudinal (>1 year)
M. The process of data collection is described (e.g. interview or self-report, etc.)
N. The loss to follow-up is described and is <20%
Results
O. The results are compared between two groups or more (e.g. healthy population, groups with different disease stages or treatment types)
TNM, tumor–node–metastasis.
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and orgasmic dysfunction in men [75]. PRT predicted
ejaculatory dysfunction in men [20, 75] and dyspareunia in
women [21]. (Neo)adjuvant chemoradiation predicted erectile
dysfunction [22] and sexual desire [76] in men. Compared with
scores before PRT, sexual dysfunction was higher at 12 months
follow-up [20, 50, 71]. Cross-sectional studies revealed the
same direction of association; more sexual (dys)function was
reported by patients who received PRT [52, 53, 90].
Having a stoma was a predictor of sexual dysfunction with a
strong level of evidence [20, 23]. Sexual dysfunction was more
often present in stoma patients compared with nonstoma
patients up to 24 months after surgery [20, 23, 63, 87].
Perioperative or postoperative complications predicted
sexual dysfunction with a strong level of evidence [20, 21, 66].
Excessive perioperative blood loss (>1500 ml) and anastomotic
leakage predicted erectile dysfunction, while anastomotic
leakage also predicted ejaculatory problems [20]. Patients with
intra-abdominal sepsis were less likely to achieve excitement
postoperatively [21]. Conversion from laparoscopic to open
surgery predicted postoperative sexual dysfunction in men
[66].
Type of surgery predicted sexual dysfunction with a
moderate level of evidence [21, 22, 66, 97, 99, 102]. Patients in a
colonic resection group reported more sexual desire and sexual
activity at 3 months follow-up compared with a rectal resection
group, although levels were similar at 6 months [66]. Cross-
sectional studies also found less sexual dysfunction after a
colonic versus rectal cancer surgery [65, 95]. In rectal cancer
surgery, APR predicted less sexual activity [99], more erectile
dysfunction in men [97], and more dyspareunia in women
[97]. Less sexual dysfunction was reported in patients who
underwent AR compared with patients who underwent APR
up to 12 months after surgery [5, 21, 22, 41, 102]. In
concordance, cross-sectional studies ruled in favor of AR [34,
51, 52, 97, 99]. Mixed results were found regarding
laparoscopic versus open surgery for rectal cancer; some studies
rule in favor of laparoscopic surgery [85, 98], others for open
surgery [22, 100], and some remain inconclusive [5, 41].
Finally, pelvic autonomic nerve preservation (PANP) yielded
good results in terms of sexual (dys)function [68, 70, 77]. The
degree of sexual dysfunction depended on the degree of PANP
[72]. Cross-sectional studies confirm these results [62, 83].
A lower tumor location predicted sexual dysfunction with a
moderate level of evidence [22, 76, 84]. A smaller distance
between the tumor and the anal verge predicted erectile
dysfunction [22, 76, 84], intercourse satisfaction [76], and
orgasmic functioning [76].
Inconclusive evidence was found for tumor stage [75] and
time since surgery [75, 76].
sociodemographic aspects in relation to sexual
dysfunction
An elderly age predicted sexual dysfunction with a strong level
of evidence [20, 21, 75, 76, 81, 97, 99]. Cross-sectional studies
revealed a similar association [29, 84, 93, 97, 99, 103, 107].
An increasing age predicted a loss of sexual activity [20, 21, 75,
81, 97, 99] and worse orgasmic functioning [21, 75, 81].
For women, an increasing age predicted worse arousal, less
dyspareunia, and less intercourse per month [21]. For men, a
higher age predicted lower sexual desire [76] and worse erectile
functioning [75, 84].
How being a man or a woman influences sexual
(dys)function remains unclear. Women were found to be less
sexually active [20]. Although both sexually active men and
women suffered from sexual dysfunction, a trend notified of
more sexual dysfunction in men compared with women up
to 24 months after surgery [20, 69].
treatment-related and sociodemographic aspects
in relation to quality of sexual life
Insufficient evidence was found for the predictive value of
treatment-related or sociodemographic factors on the quality of
sexual life. Type of operation (APR versus AR or a transanal
excision) and RT predicted a positive answer on the statement
‘surgery made my sexual life worse’ [99]. Limited moderations
were seen for sexual enjoyment in the first year after surgery
[48, 50, 57]. Patients in the colonic resection group reported
more sexual enjoyment compared with patients in the rectal
resection group [66]. Compared with healthy controls, patients
with rectal cancer reported lower scores on sexual enjoyment
[63]. A worse quality of sexual life was found for stoma patients
compared with nonstoma patients [64].
For men, sexual satisfaction decreased after surgery [5, 38,
76]. Cross-sectional studies revealed the same association [74,
86]. At a median follow-up period of 5 years, 64% of men
reported to be unsatisfied with their current sexual functioning
[88]. Few studies have examined sexual satisfaction/experiences
in women. However, one qualitative study examined how
women with permanent ostomies restructure their ideas of
sexuality [94]. Some women did not present long-term
challenges and were able to have intercourse with their
husbands, while other women had to find other erotic activities,
such as oral sex. Thus, these women were able to maintain a
sexual relationship. Other women chose not to be sexually
active anymore because of their age or because they were unable
to reconcile their own experience of disgust or the potential
reactions of a sexual partner to their ostomy. This study
concluded that neither sexual nor intimate acts were essential to
Table 2. Levels of evidence
Level of evidence Criteria
Strong Consistent findings (‡75%) in at least two high-quality studies or one high-quality study and at least three moderate studies
Moderate Consistent findings (‡75%) in one high-quality study and at least one low-quality study or at least three moderate studies
Weak Findings of two moderate studies or consistent findings (‡75%) in at least three or more low-quality studies
Inconclusive Inconsistent findings irrespective of study quality or less than three low-quality studies available













the well-being of these women. Sexual satisfaction was lower
for stoma than for nonstoma patients in one study [86] but
not in another one [93].
No studies reported on the association between
sociodemographic factors and the quality of sexual life.
discussion
The objective of this qualitative systematic review was to
provide an overview of studies that addressed sexual
(dys)function and/or the quality of sexual life in colorectal
cancer, with regard to (i) the prevalence of sexual (dys)function
and (ii) treatment-related and sociodemographic aspects in
relation to sexual (dys)function and the quality of sexual life.
This review included 82 studies. However, measuring sexual
(dys)function and/or the quality of sexual life was a secondary
objective in 39 (48%) of the studies. Since the selected
studies differed regarding the targeted study population, study
design, and outcome measures, definite conclusions regarding
the prevalence of sexual (dys)function and clinical and
sociodemographic factors associated with sexual
(dys)function and the quality of sexual life cannot be made.
Methodologically, there is room for improvement.
Approximately half of the studies were cross-sectional. In order
to detect short-term and long-term effects is necessary to use a
prospective design with an assessment point before surgical
treatment and measurement points up to at least 1 year
postoperative. In addition, the sample sizes of most studies
were rather small. Besides, more data are collected for men,
perhaps partially due to the fact that women were more
reluctant to answer questions concerning sexuality [43, 48,
101]. To draw meaningful conclusions on differences
between men and women, future large sample studies should
focus on both sexes.
Furthermore, most studies used nonstandardized
measurements, which hampers comparisons across studies.
Most studies measured sexual (dys)function and/or the quality
of sexual life with a limited number of questions. Also, in
several instruments (e.g. EORTC QLQ-CR38), questions are
only completed if the person indicated to be sexually active.
Furthermore, most questionnaires did not provide definitions
for the concepts used such as ‘sexual activity’. Some patients
will interpret sexual activity as sexual intercourse, while
others might feel that intimacy, touching, and kissing constitute
sexual activity. It is therefore difficult to draw meaningful
conclusions from the current data. In future studies, an
explicit definition of the concept of interest is warranted. The
selection of instruments should be based on systematic
reasoning and will depend on how the objectives and the
concepts of interest are conceptualized [25]. If the study
objective is to measure sexual (dys)function after a colorectal
cancer treatment, the use of more biomedical instruments (e.g.
the FSFI for women, the IIEF for men, or physiological
measurements) is satisfactory. If the objective is to describe the
subjective evaluation of a patient’s sexual (dys)function, then
instruments measuring the quality of sexual life are needed,
such as the Golombok Rust Inventory of Sexual Satisfaction
[108]. However, as pointed out by Arrington et al. [109], the
best way to measure sexual function remains uncertain. To
our knowledge, there are still no questionnaires available that
are suitable for both sexes of all sexual preferences in both
healthy and cancer populations. In this perspective, qualitative
methodologies may be a good starting point in order to
examine the experience and meaning of sexuality.
The reviewed studies mostly evaluated sexual intercourse
and/or the presence of a sexual dysfunction, while other aspects
of sexuality (e.g. oral sex, hugging or kissing, and the quality of
sexual life) were often omitted. Moreover, having a sexual
dysfunction may lead to a diminished quality of sexual life,
though this is not a necessity. Patients may have a sexual
dysfunction (e.g. erectile dysfunction) without being bothered
by it; in turn, they may also experience a diminished quality of
sexual life (e.g. due to a low sexual desire) without having
an apparent sexual dysfunction [12]. Furthermore, the current
heteronormative vision of sexuality (i.e. the vision that
sexual and marital relations are between a man and a woman)
limits the way we think about sexuality and/or capturing its
experience and meaning. For instance, questionnaires assessing
sexuality can only be filled in by persons in a heterosexual
relationship (e.g. ‘Do you find your vagina is so tight that your
partner’s penis can’t enter it?’ for women and ‘How often
were you able to penetrate (enter) your partner?’ for men).
Sexuality should be seen from a biopsychosocial perspective,
hereby taking into account the quality of sexual life. Moreover,
the relationship between psychosocial factors (e.g. self-esteem,
body image, fatigue, loss of independence, depressive
symptoms, personality characteristics, and the partners’ feelings
about the patients’ disease or appearance) and sexual
(dys)function and/or the quality of sexual life in patients with
colorectal cancer should be investigated more extensively.
Though patients with colon cancer may have better functional
results, it can be expected that they suffer from psychosocial
problems to the same extent as patients with rectal cancer.
In addition, little is known on how partners of patients with
colorectal cancer cope with the changed situation and on the
interaction between partners and patients, even though it is
known that a sexual dysfunction and the lack of affection are
some of the most commonly identified marital problems in
couples with an ill partner [110]. Furthermore, it would be
interesting to investigate if there are nonsexual forms of
intimacy that may replace sexual activity but still enable a
couple to experience companionship and to maintain a
satisfactory relationship. The partner relationship satisfaction is
an important aspect of psychological well-being and thus
quality of life. A diminished marital satisfaction may therefore
diminish quality of life. Overall, knowledge on these topics is a
prerequisite for providing adequate support for patients
with colorectal cancer and their partners.
Finally, colorectal cancer is a disease that mostly affects the
elderly. There has been an ongoing debate on whether or not
sexual dysfunction in a higher age is normal or pathological
[111]. A recent cross-sectional study reported lower sexual
functioning for patients with colorectal cancer compared with
an age-matched general population [112]. This may indicate
that colorectal cancer causes an additional negative effect on
sexual functioning. Future research should investigate the
effect of sociodemographic variables, such as age and gender,
more extensively.
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There is an important task for researchers to provide more
information on the potential effects of a colorectal cancer
diagnosis and/or the effects of treatment to health professionals
so that they in turn can inform patients on the possible
outcomes of multimodality treatment. Information about the
nature of treatment, including the side-effects (both biological
and psychosocial) that can occur, gives patients the opportunity
to include sexual issues in the decision-making process [113].
However, only 1 of 10 patients remembered discussing sexual
effects of treatment before surgery [99]. If the professional
initiates such a discussion, this may act in an empowering
way to give license to patients to discuss these issues.
conclusions
Most studies on sexual (dys)function following colorectal
cancer surgery suffer from methodological problems, such as a
cross-sectional design, a small sample size, and the use of
nonstandardized measurements. In future research, sexuality
should be investigated prospectively from a biopsychosocial
model. In this biopsychosocial model, the subjective evaluation
of sexual (dys)function, hence the quality of sexual life, and
psychological factors associated with or predictive of sexual
(dys)function and the quality of sexual life should be taken into
account.
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